While monocytes from both HCs and CTCL patients significantly upregulated HLA-DR after administration of IFN-γ, the magnitude of upregulation was significantly greater in HCs (Figure 3D). The gene discussed is IFNG; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.